UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1451
DELISTED
CSG Systems International
CSGS
| $4.19M | ﹤0.01% |
65,142
-65,925
| -50% | -$4.2M |
2013 Q2
49 quarters
|
|
1452
Hawaiian Electric Industries
HE
$1.48B
| $4.19M | ﹤0.01% |
379,705
-265,006
| -41% | -$3.02M |
2013 Q2
49 quarters
|
|
1453
Philips
PHG
$25.2B
| $4.17M | ﹤0.01% |
+158,688
| New | +$4.07M |
2025 Q3
0 quarters
|
|
1454
Intellia Therapeutics
NTLA
$1.6B
| $4.17M | ﹤0.01% |
241,282
-396,579
| -62% | -$4.88M |
2019 Q2
25 quarters
|
|
1455
Goodyear
GT
$1.24B
| $4.17M | ﹤0.01% |
557,066
-348,448
| -38% | -$3.28M |
2013 Q2
49 quarters
|
|
1456
United Parks & Resorts
PRKS
$1.47B
| $4.16M | ﹤0.01% |
80,409
-49,005
| -38% | -$2.47M |
2014 Q4
43 quarters
|
|
1457
Phinia Inc
PHIN
$2.12B
| $4.16M | ﹤0.01% |
72,314
-57,645
| -44% | -$3.11M |
2023 Q3
8 quarters
|
|
1458
Scholar Rock
SRRK
$4.86B
| $4.09M | ﹤0.01% |
109,904
-95,181
| -46% | -$3.33M |
2020 Q3
20 quarters
|
|
1459
First Busey Corp
BUSE
$2.43B
| $4.09M | ﹤0.01% |
176,600
-92,347
| -34% | -$2.2M |
2017 Q3
32 quarters
|
|
1460
First Merchants
FRME
$2.49B
| $4.09M | ﹤0.01% |
108,376
-84,187
| -44% | -$3.36M |
2015 Q1
42 quarters
|
|
1461
Dillards
DDS
$10.4B
| $4.08M | ﹤0.01% |
6,636
-3,619
| -35% | -$1.87M |
2020 Q3
20 quarters
|
|
1462
Clarivate
CLVT
$1.13B
| $4.06M | ﹤0.01% |
1,059,141
-540,747
| -34% | -$2.27M |
2021 Q2
17 quarters
|
|
1463
Provident Financial Services
PFS
$2.9B
| $4.05M | ﹤0.01% |
209,907
-150,092
| -42% | -$2.86M |
2013 Q2
49 quarters
|
|
1464
Enovis
ENOV
$1.13B
| $4.04M | ﹤0.01% |
133,208
-96,087
| -42% | -$2.91M |
2013 Q2
49 quarters
|
|
1465
Freshworks
FRSH
$3.59B
| $4.04M | ﹤0.01% |
343,212
-679,933
| -66% | -$9.16M |
2021 Q3
16 quarters
|
|
1466
Horace Mann Educators
HMN
$1.88B
| $4.03M | ﹤0.01% |
89,217
-96,386
| -52% | -$4.24M |
2013 Q2
49 quarters
|
|
1467
Perdoceo Education
PRDO
$2.11B
| $4.02M | ﹤0.01% |
106,831
-105,055
| -50% | -$3.37M |
2015 Q2
41 quarters
|
|
1468
Towne Bank
TOWN
$3.24B
| $4.02M | ﹤0.01% |
116,247
-102,854
| -47% | -$3.69M |
2015 Q3
40 quarters
|
|
1469
AvePoint
AVPT
$3.03B
| $4.02M | ﹤0.01% |
267,692
+201,542
| +305% | +$3.38M |
2023 Q1
10 quarters
|
|
1470
HUB Group
HUBG
$1.62B
| $4.01M | ﹤0.01% |
116,571
-87,630
| -43% | -$3.13M |
2013 Q2
49 quarters
|
|
1471
Par Pacific Holdings
PARR
$4.18B
| $4.01M | ﹤0.01% |
113,280
-85,817
| -43% | -$2.79M |
2015 Q4
39 quarters
|
|
1472
NexPoint Residential Trust
NXRT
$469M
| $4M | ﹤0.01% |
124,258
+101,088
| +436% | +$3.33M |
2018 Q1
30 quarters
|
|
1473
Pediatrix Medical
MD
$2.22B
| $3.99M | ﹤0.01% |
238,305
-169,558
| -42% | -$2.54M |
2023 Q1
10 quarters
|
|
1474
John Wiley & Sons Class A
WLY
$2.67B
| $3.97M | ﹤0.01% |
98,153
-76,643
| -44% | -$3.09M |
2013 Q2
49 quarters
|
|
1475
Innodata
INOD
$1.82B
| $3.97M | ﹤0.01% |
51,540
-17,023
| -25% | -$860K |
2025 Q1
2 quarters
|
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.